Ann E Kearns1, Rachel P Espiritu1, Kristin Vickers Douglass2, Prabin Thapa3, Robert A Wermers1. 1. Department of Internal Medicine, Division of Endocrinology, Diabetes, Nutrition, and Metabolism, Mayo College of Medicine, Mayo Clinic, Rochester, Minnesota. 2. Department of Psychiatry, Mayo College of Medicine, Mayo Clinic, Rochester, Minnesota. 3. Department of Health Sciences Research, Mayo College of Medicine, Mayo Clinic, Rochester, Minnesota.
Abstract
OBJECTIVE: Several studies indicate that patients with primary hyperparathyroidism (PHPT) undergoing parathyroid surgery have improvement in mood and neuropsychological functioning. The current analysis aims to examine the relationship between biochemical and clinical variables and the improvement in depression scores and in specific symptoms, after parathyroidectomy. DESIGN: A prospective observational case-control study at a referral centre. PATIENTS: Patients with PHPT undergoing parathyroidectomy (n = 88) or thyroid surgery (n = 85). MEASUREMENTS: The Patient Health Questionnaire-9 (PHQ-9) was utilized to obtain depression scores at enrolment and 12 months after surgery. The changes in PHQ-9 were analysed and correlated with baseline clinical and biochemical parameters. RESULTS: At enrolment, there was no difference between the groups in the number with a depression diagnosis (PHPT 34.1%, thyroid surgery, 35.5%, P = 0.86). However, baseline PHQ-9 scores were significantly higher in PHPT (median 7.5, range 0-27) than thyroid surgery patients (median 3.0, range 0-18, P < 0.0001). Following surgery, all PHQ-9 scores, total and symptom group (cognitive, somatic) improved and were no longer different between PHPT (total PHQ-9 median 2, range 0-16) and thyroid (median 1, range 0-14, P = 0.31) groups. Baseline parathyroid hormone level, but not calcium, had a weak relationship with change in PHQ-9 score after parathyroid surgery (P = 0.003). Baseline PHQ-9 score was correlated with change in PHQ-9 score at 12 months after parathyroid surgery (P < 0.001). CONCLUSIONS: Depression scores improve in both somatic and cognitive domains after parathyroidectomy for PHPT and baseline severity of depression predicts the response.
OBJECTIVE: Several studies indicate that patients with primary hyperparathyroidism (PHPT) undergoing parathyroid surgery have improvement in mood and neuropsychological functioning. The current analysis aims to examine the relationship between biochemical and clinical variables and the improvement in depression scores and in specific symptoms, after parathyroidectomy. DESIGN: A prospective observational case-control study at a referral centre. PATIENTS: Patients with PHPT undergoing parathyroidectomy (n = 88) or thyroid surgery (n = 85). MEASUREMENTS: The Patient Health Questionnaire-9 (PHQ-9) was utilized to obtain depression scores at enrolment and 12 months after surgery. The changes in PHQ-9 were analysed and correlated with baseline clinical and biochemical parameters. RESULTS: At enrolment, there was no difference between the groups in the number with a depression diagnosis (PHPT 34.1%, thyroid surgery, 35.5%, P = 0.86). However, baseline PHQ-9 scores were significantly higher in PHPT (median 7.5, range 0-27) than thyroid surgery patients (median 3.0, range 0-18, P < 0.0001). Following surgery, all PHQ-9 scores, total and symptom group (cognitive, somatic) improved and were no longer different between PHPT (total PHQ-9 median 2, range 0-16) and thyroid (median 1, range 0-14, P = 0.31) groups. Baseline parathyroid hormone level, but not calcium, had a weak relationship with change in PHQ-9 score after parathyroid surgery (P = 0.003). Baseline PHQ-9 score was correlated with change in PHQ-9 score at 12 months after parathyroid surgery (P < 0.001). CONCLUSIONS: Depression scores improve in both somatic and cognitive domains after parathyroidectomy for PHPT and baseline severity of depression predicts the response.
Authors: Sanziana A Roman; Julie Ann Sosa; Linda Mayes; Eric Desmond; Leon Boudourakis; Rong Lin; Peter J Snyder; Elizabeth Holt; Robert Udelsman Journal: Surgery Date: 2005-12 Impact factor: 3.982
Authors: Rachel P Espiritu; Ann E Kearns; Kristin S Vickers; Clive Grant; Euijung Ryu; Robert A Wermers Journal: J Clin Endocrinol Metab Date: 2011-09-14 Impact factor: 5.958
Authors: Hassan Kahal; Mo Aye; Alan S Rigby; Thozhukat Sathyapalan; R J A England; Stephen L Atkin Journal: Clin Endocrinol (Oxf) Date: 2012-02 Impact factor: 3.478
Authors: D S Rao; M Honasoge; G W Divine; E R Phillips; M W Lee; M R Ansari; G B Talpos; A M Parfitt Journal: J Clin Endocrinol Metab Date: 2000-03 Impact factor: 5.958
Authors: Shivani Shah-Becker; Jonathan Derr; Benjamin S Oberman; Aaron Baker; Brian Saunders; Michele M Carr; David Goldenberg Journal: Laryngoscope Date: 2017-05-16 Impact factor: 3.325
Authors: Theresia Weber; Monika Keller; Isabella Hense; Alexander Pietsch; Ulf Hinz; Tobias Schilling; Peter Nawroth; Ernst Klar; Markus W Büchler Journal: World J Surg Date: 2007-06 Impact factor: 3.282